KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIAT
Ratios

Novavax (NVAX) Long-Term Debt Issuances (2016)

Historic Long-Term Debt Issuances for Novavax (NVAX) over the last 3 years, with Q1 2016 value amounting to $325.0 million.

  • Novavax's Long-Term Debt Issuances changed N/A to $325.0 million in Q1 2016 from the same period last year, while for Dec 2016 it was $325.0 million, marking a year-over-year change of. This contributed to the annual value of $175.2 million for FY2022, which is N/A changed from last year.
  • According to the latest figures from Q1 2016, Novavax's Long-Term Debt Issuances is $325.0 million.
  • Over the past 5 years, Novavax's Long-Term Debt Issuances peaked at $325.0 million during Q1 2016, and registered a low of $100000.0 during Q1 2012.
  • For the 3-year period, Novavax's Long-Term Debt Issuances averaged around $65.4 million, with its median value being $641000.0 (2013).
  • The largest annual percentage gain for Novavax's Long-Term Debt Issuances in the last 5 years was 70900.0% (2013), contrasted with its biggest fall of 70900.0% (2013).
  • Novavax's Long-Term Debt Issuances (Quarter) stood at $550000.0 in 2012, then grew by 16.55% to $641000.0 in 2013, then surged by 50602.03% to $325.0 million in 2016.
  • Its Long-Term Debt Issuances was $325.0 million in Q1 2016, compared to $641000.0 in Q2 2013 and $809000.0 in Q1 2013.